A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan®) Versus 0.3% Hypromellose Gel (Genteal Gel®; Placebo) for the Treatment of Herpes Zoster Keratitis

Project: Research project

StatusActive
Effective start/end date4/1/143/31/20

Funding

  • Bausch & Lomb Pharmaceuticals, Inc. (Agmt 6/1/13)